Mutational analysis of the HIV-1 LTR as a promoter of negative sense transcription

Archives of Virology

Volumn 149, Issue 12, 2004, Pages 2277-2294

  Bentley, K ^a   Deacon, N ^a   Sonza, S ^a   Zeichner, S ^b   Churchill, M ^a  

^a BURNET INSTITUTE   (Australia)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LEUKEMIA CELL LINE; LONG TERMINAL REPEAT; METABOLISM; MUTATION; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PROMOTER REGION; UPREGULATION;

DNA MUTATIONAL ANALYSIS; DOWN-REGULATION; GENE EXPRESSION REGULATION, VIRAL; GENE PRODUCTS, TAT; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; JURKAT CELLS; MUTATION; PROMOTER REGIONS (GENETICS); TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; UP-REGULATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 11244348984     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-004-0386-8     Document Type: Article

References (55)

1. Al-Harthi L, Roebuck K (1998) Human immunodeficiency virus type-1 transcription: role of the 5′-untranslated leader region (Review). Int J Molec Med 1: 875-881
2. Battistini A, Marsili G, Garbanti M, Ensoli B, Hiscott J (2002) IRF regulation of HIV-1 long terminal repeat activity. J Interferon Cytokine Res 22: 27-37
3. Bell B, Sadowski I (1996) Ras-responsiveness of the HIV-1 LTR requires RBF-1 and RBF-2 binding sites. Oncogene 13: 2687-2697
4. Brigati C, Giacca M, Noonan D, Albini A (2003) HIV Tat, its TARgets and the control of viral gene expression. FEMS Microbiol Lett 220: 57-65
5. Briquet S, Vaquera C (2002) Immunolocalization studies of an antisense protein in HIV-1 infected cells and viral particles. Virology 292: 177-184
6. Briquet S, Richardson J, Vanhee-Brossollet C, Vaquera C (2001) Natural antisense transcripts are detected in different cell lines and tissues of cats infected with feline immunodeficiency virus. Gene 267: 157-164
7. Bukrinsky M, Etkin A (1990) Plus strand of the HIV provirus DNA is expressed at early stages of infection. AIDS Res Hum Retrovir 6: 425-426
8. Burke T, Kadonaga J (1996) Drosophila TFIID binds to a conserved downstream basal promoter element that is present in many TATA-box-deficient promoters. Genes Dev 10: 711-724
9. Cannone-Hergaux R, Aunis D, Schaeffer E (1995) Interactions of the transcription factor AP-1 with the long terminal repeat of different human immunodeficiency virus type 1 strains in Jurkat, glial, and neuronal cells. J Virol 69: 6634-6642
10. Churchill M, Ramsay R, Rhodes D, Pereira L, Deacon N (2001) c-Myb influences HIV-1 gene expression and virus production. AIDS Res Hum Retrovir 17: 1481-1488
11. Churcher M, Lamont C, Hamy F, Dingwall C, Green S, Lowe A, Butler P, Gait M, Karn J (1993) High affinity binding of TAR RNA by the human immunodeficiency virus Tat protein requires amino acid residues flanking the basic domain and base pairs in the RNA stem. J Mol Biol 230: 90-110
12. Cooney A, Tsai S, O'Malley B, Tsai M (1991) Chicken ovalbumin upstream promoter transcription factor binds to a negative regulatory region in the human immunodeficiency virus type 1 long terminal repeat. J Virol 65: 2853-2860
13. Croager EJ, Gout AM, Abraham LJ (2000) Involvement of Sp1 and microsatellite repressor sequences in the transcriptional control of the human CD30 gene. Am J Pathol 156: 1723-1732
14. Cujec T, Cho H, Maldonado E, Meyer J, Reinberg D, Peterlin B (1997) The human immunodeficiency virus transactivator Tat interacts with the RNA polymerase II haloenzyme. Mol Cell Biol 17: 1817-1823
15. Cullen B (1991) Regulation of gene expression in the human immunodeficiency virus type 1. Adv Virus Res 40: 1-17
16. Dasgupta P, Saikumar P, Reddy D, Reddy E (1990) The cellular proto-oncogene product Myb acts as a transcriptional activator of the long terminal repeat of human T-lymphotropic virus type 1. J Virol 87: 8090-8094
17. Feig L, Cooper G (1988) Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP. Mol Cell Biol 8: 3235-3243
18. Graeble M, Churcher M, Lowe A, Gait M, Karn J (1993) Human immunodeficiency virus type 1 trans-activator protein Tat stimulates transcriptional read through of distal terminator sequences in vitro. Proc Natl Acad Sci USA 90: 6184-6188
19. Hewitson A, Chilton BS (2003) An Sp1-NF-Y/progesterone receptor DNA binding-dependent mechanism regulates progesterone-induced transcriptional activation of the rabbit RUSH/SMARCA3 gene. J Biol Chem 278: 40177-40185
20. Jakobovits E, Schlokat U, Vannice J, Derynck R, Levinson A (1988) The human transforming growth factor alpha promoter directs transcription initiation from a single site in the absence of a TATA sequence. Mol Cell Biol 8: 5549-5554
21. Jeong JH, Orvis J, Kim JW, McMurtrey CP, Renne R, Dittmer DP (2004) Regulation and autoregulation of the promoter for the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J Biol Chem 279: 16822-16831
22. Jones K, Peterlin B (1994) Control of RNA initiation and elongation at the HIV-1 promoter. Annu Rev Biochem 63: 717-743
23. Jones K, Kadonaga J, Luciw P, Tjian R (1986) Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1. Science 232: 755-759
24. Jordan A, Defechereux P, Verdin E (2001) The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation. EMBO J 20: 1726-1738
25. Jordan A, Bisgrove D, Verdin E (2003) HIV-1 reproducibly establishes a latent infection after acute infection of T cells in vitro. EMBO J 22: 1868-1877
26. Kiehl A, Huang L, Franci D, Anders DG (2003) Multiple 5′ ends of human cytomegalovirus UL57 transcripts identify a complex, cycloheximide- resistant promoter region that activates oriLyt. Virology 314: 410-422
27. Kim J, Gonzalez-Scarano F, Zeichner S, Alwine J (1993) Replication of type 1 human immunodeficiency viruses containing linker substitution mutations in the -201 to -130 region of the long terminal repeat. J Virol 67: 1658-1662
28. Larocca D, Chao L, Seto M, Brunck T (1989) Human T-cell leukemia virus minus strand transcription in infected T-cells. Biochem Biophys Res Comm 163: 1006-1013
29. Leonard J, Parrott C, Buckler-White A, Turner W, Ross E, Martin M, Rabson A (1989) The NF-kappa B binding sites in the human immunodeficiency virus type 1 long terminal repeat are not required for virus infectivity. J Virol 63: 4919-4924
30. Ljutic B, Carlyle JR, Zuniger-Pflucker JC (2003) Identification of upstream cis-acting regulatory elements controlling lineage-specific expression of the mouse NK cell activation receptor, NKR-P1C. J Biol Chem 278: 31909-31917
31. Mancebo H, Lee G, Flygare J, Tomassini J, Luu P, Zhu Y, Peng J, Blau C, Hazuda D, Price D, Flores O (1997) P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes Dev 11: 2633-2644
32. Marzio G, Tyagi M, Gutierrez M, Giacca M (1998) HIV-1 Tat transactivator recruits p300 and CREB-binding protein histone acetyltransferase to the viral promoter. Proc Natl Acad Sci USA 95: 13519-13524
33. Michael N, Vahey M, D'Arcy L, Ehrenberg P, Mosca J, Rappaport J, Redfield R (1994) Negative-strand RNA transcripts are produced in human immunodeficiency virus type 1-infected cells and patients by a novel promoter downregulated by Tat. J Virol 68: 979-987
34. Miller RH (1988) Human immunodeficiency virus may encode a novel protein on the genomic plus strand. Science 239: 1420-1422
35. Pazin M, Sheridan P, Cannon K, Cao Z, Keck J, Kadonaga J, Jones K (1996) NF-κB-mediated chromatin reconfiguration and transcriptional activation of the HIV-1 enhancer in vitro. Gen Dev 10: 37-49
36. Peeters A, Lambert P, Deacon N (1996) A fourth Sp1 site in the human immunodeficiency virus type 1 long terminal repeat is essential for negative-sense transcription. J Virol 70: 6665-6672
37. Pereira L, Bentley K, Peeters A, Churchill M, Deacon N (2000) A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter. Nucleic Acids Res 28: 663-668
38. Rittner K, Churcher M, Gait M, Karn J (1995) The human immunodeficiency virus long terminal repeat includes a specialised initiator element which is required for Tat-responsive transcription. J Mol Biol 248: 562-580
39. Sadaie M, Mukhopadhyaya R, Benaissa Z, Pavlakis G, Wong-Staal F (1990) Conservative mutations in the putative metal-binding region of human immunodeficiency virus tat disrupt virus replication. AIDS Res Hum Retrovir 6: 1257-1263
40. Sieweke MHT, Jaroche U, Graf T (1998) Cooperative interaction of Ets-1 with USF-1 required for HIV-1 enhancer activity in T cells. EMBO J 17: 1728-1739
41. Smale S, Baltimore D (1989) The "initiator" as a transcriptional control element. Cell 57: 103-113
42. Sonza S, Mutimer HP, O'Brien K, Ellery P, Howard JL, Axelrod JH, Deacon NJ, Crowe SM, Purcell D (2002) Selectively reduced tat mRNA heralds the decline in productive human immunodeficiency virus type 1 infection in monocyte-derived macrophages. J Virol 76: 12611-12621
43. Thomas R, Timms M, Seth A, Shannon M, Kola I (1995) ETS1 transactivates the human GM-CSF promoter in Jurkat cells stimulated with PMA and ionomycin. Oncogene 11: 2135-2143
44. Vanhee-Brossollet C, Vaquera C (1998) Do natural antisense transcripts make sense in eukaryotes? Gene 211: 1-9
45. + individuals. Virology 206: 196-202
46. Vijh S, Dayhoff DE, Wang CE, Imam Z, Ehrenberg PK, Michael NL (2002) Transcription regulation of human chemokine receptor CCR3: evidence for a rare TATAless promoter structure conserved between drosophila and humans. Genomics 80: 86-95
47. Wagner E, Simons R (1994) Antisense RNA controlling bacteria, phages and plasmids. Annu Rev Microbiol 48: 713-742
48. Wang L-H, Tsai S, Sagami I, Tsai M, O'Malley M (1987) Purification and characterisation of chicken ovalbumin upstream promoter transcription factor from HeLa cells. J Biol Chem 262: 16080-16086
49. Wassef NM, Young J, Miller R (2003) Viral reservoirs/transient infection in HIV/AIDS: Where are we now and where should we go? AIDS Res Hum Retrovir 19: 333-344
50. Wei P, Garber M, Fang S, Fischer W, Jones K (1998) A novel CDK9-associated c-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92: 451-462
51. Yamamoto R, Mori S, Okamoto T, Shimotohno K, Kyogoku Y (1991) Identification of transcriptional suppressor proteins that bind to the negative regulatory element of the human immunodeficiency virus type 1. Nucleic Acids Res 19: 6107-6112
52. Yang Z, Engel J (1993) Human T cell transcription factor GATA-3 stimulates HIV-1 gene expression. Nucleic Acids Res 21: 2831-2936
53. Zeichner S, Kim J, Alwine J (1991a) Analysis of the human immunodeficiency virus long terminal repeat by in vitro transcription competition and linker scanning mutagenesis. Gene Expr 1: 15-27
54. Zeichner S, Kim J, Alwine J (1991b) Linker-scanning mutational analysis of the human immunodeficiency virus type 1 long terminal repeat. J Virol 65: 2436-2444
55. Zhou T, Chiang CM (2001) The intronless and TATA-less human TAF(II)55 gene contains a functional initiator and a downstream promoter element. J Biol Chem 276: 25503-25511